Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Form 8 (OPD) - Nucleus Financial Platforms Limited

9 Dec 2022 07:00

RNS Number : 1347J
Nucleus Financial Platforms Limited
09 December 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Nucleus Financial Platforms Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Curtis Banks Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

8 December 2022

 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

ORDINARY SHARES OF 0.5p EACH

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Interests in ordinary shares of 0.5 pence each in Curtis Banks Group plc held by persons acting in concert with Nucleus Financial Platforms Limited

Name

Number of ordinary shares

Percentage of issued share capital (per cent.)

N/A

N/A

N/A

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

09 December 2022

Contact name:

Alice Dixie, Nucleus Financial Platforms Limited

Telephone number:

+44 (0)77 0255 5615

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEETPBPTMTBMBMT
Date   Source Headline
17th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
17th Jan 202311:56 amRNSForm 8.5 (EPT/RI)
17th Jan 202311:23 amRNSDirector/PDMR Shareholding
16th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
16th Jan 202311:41 amRNSHolding(s) in Company
16th Jan 20239:43 amRNSForm 8.5 (EPT/RI)
13th Jan 202312:47 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
13th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
13th Jan 202311:54 amRNSForm 8.5 (EPT/RI)
12th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
12th Jan 20239:30 amRNSForm 8.5 (EPT/RI)
11th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
11th Jan 20239:42 amRNSForm 8.5 (EPT/RI)
10th Jan 20231:06 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
10th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
10th Jan 20239:38 amRNSForm 8.5 (EPT/RI)
10th Jan 20237:00 amRNSBoard appointment
9th Jan 20233:47 pmRNSForm 8.3 - Curtis Banks Plc
9th Jan 20233:02 pmRNSForm 8.3 - Curtis Banks Group PLC
9th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
9th Jan 202311:27 amRNSForm 8.5 (EPT/RI)
6th Jan 20231:17 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
6th Jan 202312:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
6th Jan 202310:05 amRNSRecommended Cash Offer for Curtis Banks Group PLC
6th Jan 20239:50 amRNSForm 8.5 (EPT/RI)
5th Jan 202310:20 amRNSForm 8.5 (EPT/RI)
5th Jan 20239:07 amRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
4th Jan 20239:35 amRNSForm 8.5 (EPT/RI)
4th Jan 20238:59 amRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
3rd Jan 20231:28 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
3rd Jan 202312:03 pmRNSForm 8.5 (EPT/RI)
30th Dec 20222:14 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
30th Dec 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
29th Dec 20222:28 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
29th Dec 202212:00 pmRNSForm 8.5 (EPT/RI)
29th Dec 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
28th Dec 20222:40 pmRNSForm 8.5 (EPT/RI) Replacement
28th Dec 20222:20 pmGNWForm 8.3 - Octopus Investments - Curtis Banks
28th Dec 202212:04 pmRNSForm 8.5 (EPT/RI)
28th Dec 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
23rd Dec 202210:49 amRNSForm 8.5 (EPT/RI)
23rd Dec 20229:25 amRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
23rd Dec 20227:00 amRNSStatement regarding extension to offer deadline
22nd Dec 202210:08 amRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
22nd Dec 20227:00 amRNSForm 8.3 - Curtis Banks Group PLC
22nd Dec 20227:00 amRNSForm 8.3 - Curtis Banks Group PLC
21st Dec 20221:44 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
21st Dec 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
21st Dec 202211:43 amRNSForm 8.5 (EPT/RI)
21st Dec 20229:41 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.